I agree that this site is using cookies. You can find further informations here.
X
Ďuricová, Dana
116  results:
Search for persons X
?
1

548 DISABILITY IN CROHN'S DISEASE PATIENTS AT DIAGNOSIS: FI..:

Revés, Joana ; Madsen, Gorm Roager ; Burisch, Johan M....
Gastroenterology.  166 (2024)  5 - p. S-127 , 2024
Link: https://doi.org/10.1016/..
 
?
2

FROM RESISTANCE TO RESPONSE: 52 WEEKS OF SUBCUTANEOUS INFLI..:

Lukas, Milan ; Cerna, Karin ; Duricova, Dana.
Inflammatory Bowel Diseases.  30 (2024)  Supplement_1 - p. S84-S84 , 2024
Link: https://doi.org/10.1093/..
 
?
3

Intestinal Ultrasound—Ready to Use for Early Prediction of ..:

Duricova, Dana ; Kucharzik, Torsten ; Mitrova, Katarina.
Journal of Crohn's and Colitis.  , 2024
Link: https://doi.org/10.1093/..
 
?
4

Mo1802 BOWEL DAMAGE AND ITS ASSOCIATION WITH THE DISABILITY..:

Revés, Joana ; Madsen, Gorm Roager ; Burisch, Johan M....
Gastroenterology.  166 (2024)  5 - p. S-1117-S-1118 , 2024
Link: https://doi.org/10.1016/..
 
?
5

Serological responses to vaccination in children exposed in..:

Mitrova, Katarina ; Cerna, Karin ; Zdychyncova, Kristyna...
European Journal of Pediatrics.  , 2024
Link: https://doi.org/10.1007/..
 
?
6

SUBCUTANEOUS INFLIXIMAB IN REFRACTORY CROHN'S DISEASE PATIE..:

Lukas, Milan ; Jirsa, Jakub ; Lukas, Martin...
Gastroenterology.  164 (2023)  4 - p. S97 , 2023
Link: https://doi.org/10.1053/..
 
?
7

SUBCUTANEOUS INFLIXIMAB IN REFRACTORY CROHN'S DISEASE PATIE..:

Lukas, Milan ; Jirsa, Jakub ; Lukas, Martin...
Inflammatory Bowel Diseases.  29 (2023)  Supplement_1 - p. S76-S76 , 2023
Link: https://doi.org/10.1093/..
 
?
8

EFFICIENCY OF DUAL THERAPY WITH VEDOLIZUMAB AND TOFACITINIB..:

Kolar, Martin ; Kastylova, Kristyna ; Lukas, Martin...
Inflammatory Bowel Diseases.  29 (2023)  Supplement_1 - p. S78-S78 , 2023
Link: https://doi.org/10.1093/..
 
?
9

EFFICIENCY OF DUAL THERAPY WITH VEDOLIZUMAB AND TOFACITINIB..:

Kolar, Martin ; Kastylova, Kristyna ; Lukas, Martin...
Gastroenterology.  164 (2023)  4 - p. S100 , 2023
Link: https://doi.org/10.1053/..
 
?
10

Subcutaneous Infliximab in Refractory Crohn's Disease Patie..:

Cerna, Karin ; Duricova, Dana ; Lukas, Martin...
Crohn's & Colitis 360.  5 (2023)  4 - p. , 2023
Link: https://doi.org/10.1093/..
 
?
11

Implementation and Short-term Adverse Events of Anti-SARS-C..:

Ellul, Pierre ; Revés, Joana ; Abreu, Bárbara...
Journal of Crohn's and Colitis.  16 (2022)  7 - p. 1070-1078 , 2022
Link: https://doi.org/10.1093/..
 
?
12

DUAL BIOLOGICAL OR SMALL MOLECULE TREATMENT IN INFLAMMATORY..:

Lukas, Milan ; Kolar, Martin ; Vasatko, Martin...
Gastroenterology.  162 (2022)  3 - p. S105 , 2022
Link: https://doi.org/10.1053/..
 
?
13

Cellular and Humoral Immune Responses to SARS-CoV-2 Vaccina..:

Cerna, Karin ; Duricova, Dana ; Hindos, Miroslav...
Journal of Crohn's and Colitis.  16 (2022)  9 - p. 1347-1353 , 2022
Link: https://doi.org/10.1093/..
 
?
14

Tu1549: IMPLEMENTATION AND SHORT-TERM ADVERSE EVENTS OF ANT..:

Revés, Joana ; Abreu, Bárbara S. ; Chaparro, María...
Gastroenterology.  162 (2022)  7 - p. S-1006 , 2022
Link: https://doi.org/10.1016/..
 
?
15

DUAL BIOLOGICAL OR SMALL MOLECULE TREATMENT IN INFLAMMATORY..:

Lukas, Milan ; Kolar, Martin ; Vasatko, Martin...
Inflammatory Bowel Diseases.  28 (2022)  Supplement_1 - p. S105-S105 , 2022
Link: https://doi.org/10.1093/..
 
1-15